Nuclear factor-κB (NF-κB)/Rel proteins include NF-κB2 p52/p100, NF-κB1 p50/p105, c-Rel, RelA/p65, and RelB.These proteins perform as two-component transcription factors that control gene expression and have an impact on a variety of biological processes, such as innate and acquired immunity, inflammation, stress responses, B-cell development, and lymphoid organogenesis.The immune system's reaction to infection is significantly regulated by NF-B. In addition, the etiology of chronic inflammatory illnesses such inflammatory bowel disease, rheumatoid arthritis, and asthma is influenced by the activation of the NF-B pathway. Septic shock, autoimmune and inflammatory disorders, viral infections, and poor immunological development have all been connected to faulty NF-B regulation.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V82294 | L-Serine-d2 ((-)-Serine-d2; (S)-Serine-d2) | 95034-57-4 | L-Serine-d2 is the deuterium labelled form of L-Serine. | |
V82277 | Lacto-N-biose I (Galβ1-3GlcNAc) | 50787-09-2 | Lacto-N-biose I (Galβ1-3GlcNAc) α1,2-focusyltransferase enzyme receptor from Helicobacter pylori, an endogenously produced metabolite. | |
V2219 | Laquinimod (ABR-215062) | 248281-84-7 | Laquinimod(also known as ABR-215062, LAQ) is a potent and orally bioactive immunoregulator being investigated for treatment of multiple sclerosis (MS). | |
V82296 | Lasiocarpine | 303-34-4 | Lasiocarpine is a hepatotoxic pyrrolizidine alkaloid (hepatotoxic PA) that can cause fatal hepatic veno-occlusive disease in the body. | |
V82224 | Licoagrochalcone C | 325144-68-1 | Licoagrochalcone C is a flavonoid with inhibitory activity on NF-κB transcription. | |
V82256 | Lucioside B | 91174-19-5 | Lucyoside B inhibits the production of inflammatory mediators through the NF-κB and activator protein-1 pathways in activated macrophages. | |
V84445 | Magnoloside F | 1945997-27-2 | ||
V84482 | MAT2A-IN-14 | |||
V84634 | MRT 68601 hydrochloride | 1962928-25-1 | ||
V85270 | Multi-target Pt | |||
V82293 | N1,N8-Diacetylspermidine | 82414-35-5 | N1,N8-Diacetylspermidine is a polyamine found in human urine. | |
V26329 | NDMC101 | 1308631-40-4 | NDMC101 is a potent osteoclastogenesis inhibitor that can suppress osteoclast differentiation by downregulating NFATc1 regulatory gene expression. | |
V31378 | Neferine | 2292-16-2 | Neferine is a bisbenzylisoquinoline alkaloid. | |
V28831 | Neochlorogenic acid | 906-33-2 | Neochlorogenic acid is a natural polyphenolic compound with anti-inflammatory activity. | |
V75096 | Neocryptotanshinone (新cryptotanshinone) | 109664-02-0 | Neocryptotanshinone is a salvia diterpene extracted from Salvia Miltiorrhiza, which inhibits lipopolysaccharide (LPS)-induced inflammation by inhibiting NF-κB and iNOS signaling. | |
V78749 | NF-κB-IN-10 | NF-κB-IN-10 (compound E1) is an NF-κB inhibitor that can reduce oxidative stress and inflammation by regulating the Nrf2/NF-κB signaling pathway, thereby improving heart failure. | ||
V80940 | NF-κB-IN-12 | NF-κB-IN-12 (compound 3h) is a potent NF-κB inhibitor (antagonist) with IC50 of 1.02 μM. | ||
V85763 | NF-κB-IN-14 | 3019972-01-8 | ||
V77644 | NF-κB-IN-9 | NF-κB-IN-9 is a sonosensitizer targeting nuclear factor NF-κB (λex/λem=489/628 nm). | ||
V26503 | NIK SMI1 | 1660114-31-7 | NIK SMI1 (NIK-SMI1) is a novel, highly selective and potent inhibitor of NF-κB-inducing kinase (NIK). |